US Patent Issued to INTRABIO on Aug. 4 for "Combination therapy with acetyl-leucine and miglustat" (British, German Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,697,316, issued on Aug. 4, was assigned to INTRABIO LTD. (London).

"Combination therapy with acetyl-leucine and miglustat" was invented by Mallory Factor (Mayfair, Great Britain) and Michael Strupp (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods of treating lysosomal storage disorders (LSDs) in a subject in need thereof by administering a combination of acetyl-leucine and miglustat to the subject, wherein subject is naive to treatment with miglustat."

The patent was filed on June 26, 2020, under Application No. 17/623,313.

*For further information, including images, charts and tables, please visit: http://...